Thought Leadership

Emerging Market-ing

Cuiding biopharma clients to on-the-ground success in “pharmerging” markets requires sensitivity, creativity, and flexibility. The biopharmaceutical industry's fascination with emerging markets is no secret. With 85% of the world's population living in the "pharmerging" markets, potential for impacting both from one another in language, political climate, and culture, these markets share in common a need for sensitivity, creativity, and flexibility.

Emerging Market-ing





© 2017 Publicis Healthcare Communications Group. All rights reserved.